Essex Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-6,139
Closed -$1.29M 388
2016
Q4
$1.29M Sell
6,139
-26,969
-81% -$5.59M 0.21% 124
2016
Q3
$7.63M Buy
33,108
+2,978
+10% +$728K 1.23% 18
2016
Q2
$6.96M Sell
30,130
-724
-2% -$167K 1.16% 20
2016
Q1
$8.27M Sell
30,854
-4,547
-13% -$1.3M 1.42% 18
2015
Q4
$11.1M Buy
35,401
+4,494
+15% +$1.34M 1.73% 11
2015
Q3
$8.4M Sell
30,907
-1,321
-4% -$406K 1.38% 17
2015
Q2
$9.78M Buy
32,228
+7,653
+31% +$2.28M 1.48% 15
2015
Q1
$7.31M Buy
24,575
+5,126
+26% +$1.46M 1.02% 25
2014
Q4
$5.01M Buy
19,449
+639
+3% +$160K 0.73% 42
2014
Q3
$4.54M Buy
18,810
+662
+4% +$148K 0.69% 42
2014
Q2
$4.05M Buy
18,148
+231
+1% +$47.8K 0.6% 43
2014
Q1
$3.69M Sell
17,917
-311
-2% -$61.6K 0.54% 47
2013
Q4
$3.06M Buy
18,228
+15,121
+487% +$2.36M 0.43% 62
2013
Q3
$447K Hold
3,107
0.07% 267
2013
Q2
$392K Buy
+3,107
New +$352K 0.07% 241

Other funds holding AGN

Essex Investment Management's AGN Position: Q1 2017 in Review

Essex Investment Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 6,139 shares — an estimated $1.29M sold.

Essex Investment Management first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $11.1M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

  • Essex Investment Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Essex Investment Management sold 6,139 Allergan plc shares in Q1 2017, an estimated $1.29M.
  • Essex Investment Management first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Essex Investment Management's Allergan plc position peaked at $11.1M in Q4 2015.
  • 1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Essex Investment Management's 13F filing for Q1 2017, filed 27 Apr 2017.